{"slug":"pt-141-nerve-damage","verification":{"valid":true,"entries":2,"head":"07a95d0b8b6edaaa356a8f7b35f9e9bfafc4a4b9b44d1c215c1786c323dbc79e"},"energy":{"passes":2,"tokens_in":33240,"tokens_out":3055,"tokens_total":36295,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"07a95d0b8b6edaaa356a8f7b35f9e9bfafc4a4b9b44d1c215c1786c323dbc79e"},"provenance":[{"ts":"2026-06-30T01:13:08.066Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Nerve Damage\nSlug: pt-141-nerve-damage\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down\",\"Why PT-141 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from","response":"{\n  \"slug\": \"pt-141-nerve-damage\",\n  \"title\": \"PT-141 for Nerve Damage: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down\\n\\nNerve damage involves layers of degeneration. Axons can break or retract after injury or toxicity. Myelin sheaths around nerves can degrade, slowing signal conduction. Schwann cells and supporting glia may fail to remyelinate or guide regrowth. Sensory and motor endpoints lose function, leading to numbness, weakness, or pain. Central nervous system components tied to arousal pathways can also show disrupted signaling if peripheral input is lost. These layers create a net where breakdown outruns natural repair, leaving persistent deficits. PT-141 is discussed here in the context of its studied effects on melanocortin pathways in the CNS that influence arousal, not as a direct nerve regenerator.\\n\\n## Why PT-141 might help you\\n\\n1. If your nerve damage affects sexual function through reduced CNS arousal signaling, PT-141 is studied because it activates melanocortin receptors (MC3R and MC4R) in brain areas linked to motivation and desire. \\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain. The compound engages central pathways that may support downstream tissue responses rather than blocking symptoms.\\n3. If peripheral nerve issues have secondarily dampened arousal circuits, the central action could interact with remaining neural pathways. \\n4. This framing stays at the sexual/CNS arousal layer; other degeneration layers require separate approaches.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\\n\\n## What the evidence actually shows\\n\\nHuman data: No clinical trials directly test PT-141 for nerve damage or neuropathy. Approved use is limited to hypoactive sexual desire disorder ","tokens_in":33240,"tokens_out":3055,"cost":0,"prev":"genesis","hash":"60ed75dd318e2a26212f9510312a950293a7c276b014bf18bc83afa25be1aa6f"},{"ts":"2026-07-17T02:41:08.026Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-nerve-damage","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"60ed75dd318e2a26212f9510312a950293a7c276b014bf18bc83afa25be1aa6f","hash":"07a95d0b8b6edaaa356a8f7b35f9e9bfafc4a4b9b44d1c215c1786c323dbc79e"}]}